Browse Studies — Arctuva

Phase 1

A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)

The purpose of this Phase 1/2 master protocol study is to evaluate if DCC-3009 is safe, tolerable and works effectively in the treatment of GIST. The study wil…

Gastrointestinal Stromal Tumor (GIST)

Estimated

~$10 – $8,750

Deciphera Pharmaceuticals, LLCNCT06630234

Phase 1

A Phase 1a/1b Study of the Safety, Pharmacokinetics, and Antitumor Activity of the Oral Menin Inhibitor Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) After Imatinib Failure

In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults wit…

Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal CancerGastrointestinal Stromal Neoplasm+2 more

Estimated

~$10 – $8,750

Kura Oncology, Inc.NCT06655246

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophagea…

Stomach CancerGastro-Esophageal(GE) Junction CancerGastric (Stomach) Cancer+2 more

Estimated

~$10 – $750

Stanford UniversityNCT01048281